| Literature DB >> 25636055 |
Maryam Mohammadi-Khanaposhtani1, Mina Saeedi2, Narges Shamsaei Zafarghandi1, Mohammad Mahdavi3, Reyhaneh Sabourian4, Elahe Karimpour Razkenari4, Heshmatollah Alinezhad5, Mahnaz Khanavi6, Alireza Foroumadi3, Abbas Shafiee3, Tahmineh Akbarzadeh7.
Abstract
A novel series of acridone linked to 1,2,3-triazole derivatives have been synthesized and evaluated in vitro for their acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities. The synthetic approach was started from the reaction of 2-bromobenzoic acid with aniline derivatives and subsequent cyclization reaction to give acridone derivatives. Then, reaction of the later compounds with propargyl bromide followed by azide-alkyne cycloaddition reaction (click reaction) led to the formation of the title compounds in good yields. Among the synthesized compounds, 10-((1-(4-chlorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)-2-methoxyacridin-9(10H)-one 9g, depicted the most potent anti-AChE activity (IC50 = 7.31 μM). Also, docking study confirmed the results obtained through in vitro experiments and predicted possible binding conformation.Entities:
Keywords: Acetylcholinesterase; Acridone-1,2,3-triazole; Alzheimer's disease; Docking study
Mesh:
Substances:
Year: 2015 PMID: 25636055 DOI: 10.1016/j.ejmech.2015.01.044
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514